drugset / Trial / NCT01279057

A Study Comparing Two Fluticasone Furoate Nasal Sprays in the Relief of the Signs and Symptoms of Seasonal Allergic Rhinitis

NCT01279057

Phase 3 Completed 727 enrolled Sandoz
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study compared the safety and efficacy of a generic fluticasone furoate (Lek Pharmaceuticals) nasal spray to the reference listed drug in the treatment of seasonal allergic rhinitis. Additionally both the test and the reference formulations were tested for superiority against a placebo nasal spray.

Timeline

Start
2010-12-27
Primary completion
2011-02-08
Completion
2011-02-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluticasone Furoate Other / unclassified 110 ug Intranasal